相关实验视频
Updated: Jun 15, 2025

09:11
Assays for Validating Histone Acetyltransferase Inhibitors
Published on: August 6, 2020
6.5K
希斯脱乙酶:对于异常性肺纤维化症的潜在治疗点
Hai-Peng Cheng1,2, Shi-He Jiang1,2, Jin Cai1,2
1Department of Pathology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Frontiers in cell and developmental biology
|August 28, 2024
概括
基因组脱乙酶 (HDACs) 与异常性肺纤维化 (IPF) 有关. 针对HDACs为这种慢性肺病提供了一个有希望的治疗策略,可能会导致新的治疗方法.
科学领域:
- 肺病学和分子生物学
- 专注于慢性纤维性肺部疾病和表观遗传调节.
背景情况:
- 异形性肺纤维化 (IPF) 是最常见的,进展性间歇性肺病,治疗选择有限.
- 基因组脱乙酶 (HDACs) 通过基因组乙化调节基因转录,影响细胞过程.
- 新出现的证据将HDAC与纤维状况的发病和进展联系在一起,包括IPF.
研究的目的:
- 在IPF的背景下审查目前对HDAC的理解.
- 探索HDAC抑制剂的潜力,作为IPF的新疗法.
- 突出HDACs作为理解IPF病因和治疗的潜在目标.
主要方法:
- 关于研究纤维性疾病中的HDAC的综合文献综述.
- 对HDAC抑制剂及其作用机制的研究分析.
- 综合有关HDACs在IPF病变发生中的作用的信息.
主要成果:
- 在慢性纤维性疾病的发展和进展中,HDACs起着重要作用.
- 针对HDACs的抑制剂显示出在纤维化肺部疾病中治疗干预的潜力.
- 特定的HDAC越来越被认为是IPF进展的关键参与者.
结论:
- HDACs是开发IPF新疗法的有希望的目标.
- 选择性抑制特定的HDAC或基因干扰可能提供一个可行的治疗策略.
- 对HDAC的进一步研究可以阐明IPF的病因,并指导治疗的发展.
相关概念视频
Histone Modification
13.2K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
13.2K
Spreading of Chromatin Modifications
8.2K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
8.2K
Chromatin Modification in iPS Cells
1.6K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
1.6K
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Actin Filament Depolymerization
3.1K
Actin filaments (F-actin) are composed of actin subunits. The dissociation of actin monomers can occur from either end of F-actin. The rate of dissociation is faster from the minus-end or the pointed end, where the actin subunits exist with a bound ADP, together known as ADP-actin. The depolymerization of F-actin is aided by proteins, including the actin-depolymerizing factor (ADF) and cofilin family of proteins, gelsolin, and glia maturation factor (GMF).
In F-actin, the ADF/cofilin proteins...
In F-actin, the ADF/cofilin proteins...
3.1K

